We observed a decrease in total ATPIF1 protein levels in all mutants tested (Fig 1E), suggesting that increased levels of ATP hydrolysis could be a shared pathogenic process among patients with mitochondrial diseases. The gene discussed is ATP5IF1; the disease is inborn mitochondrial metabolism disorder.